The announcement and subsequent closure of the Red Deer overdose prevention site in Alberta, Canada, were associated with increased opioid agonist therapy dispensing among identifiable site users. Short-term effects on acute healthcare utilization and mortality appear stable but remain inconclusive due to the limited 26-week follow-up period and low event counts.
Day et al. (Tue,) studied this question.